Cargando…

Expression of tumor antigens on primary ovarian cancer cells compared to established ovarian cancer cell lines

In order to select a suitable combination of cancer cell lines as an appropriate source of antigens for dendritic cell-based immunotherapy of ovarian cancer, we analyzed the expression level of 21 tumor associated antigens (BIRC5, CA125, CEA, DDX43, EPCAM, FOLR1, Her-2/neu, MAGE-A1, MAGE-A2, MAGE-A3...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kloudová, Kamila, Hromádková, Hana, Partlová, Simona, Brtnický, Tomáš, Rob, Lukáš, Bartůňková, Jiřina, Hensler, Michal, Halaška, Michael J., Špíšek, Radek, Fialová, Anna
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2016
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5216785/ https://www.ncbi.nlm.nih.gov/pubmed/27323861 http://dx.doi.org/10.18632/oncotarget.10028

Ejemplares similares

Distinct patterns of intratumoral immune cell infiltrates in patients with HPV-associated compared to non-virally induced head and neck squamous cell carcinoma
por: Partlová, Simona, et al.
Publicado: (2015)

Mature dendritic cells correlate with favorable immune infiltrate and improved prognosis in ovarian carcinoma patients
por: Truxova, Iva, et al.
Publicado: (2018)

Calreticulin exposure correlates with robust adaptive antitumor immunity and favorable prognosis in ovarian carcinoma patients
por: Kasikova, Lenka, et al.
Publicado: (2019)

Poly I: C-activated dendritic cells that were generated in CellGro for use in cancer immunotherapy trials
por: Fučíková, Jitka, et al.
Publicado: (2011)

Induction of Tolerance and Immunity by Dendritic Cells: Mechanisms and Clinical Applications
por: Fucikova, Jitka, et al.
Publicado: (2019)

Gene expression profiling of circulating tumor cells and peripheral blood mononuclear cells from breast cancer patients
por: Hensler, Michal, et al.
Publicado: (2015)

Peripheral gene signatures reveal distinct cancer patient immunotypes with therapeutic implications for autologous DC-based vaccines
por: Hensler, Michal, et al.
Publicado: (2022)

M2-like macrophages dictate clinically relevant immunosuppression in metastatic ovarian cancer
por: Hensler, Michal, et al.
Publicado: (2020)

Phase I/II clinical trial of dendritic-cell based immunotherapy (DCVAC/PCa) combined with chemotherapy in patients with metastatic, castration-resistant prostate cancer
por: Podrazil, Michal, et al.
Publicado: (2015)

Safety and efficacy of dendritic cell-based immunotherapy DCVAC/OvCa added to first-line chemotherapy (carboplatin plus paclitaxel) for epithelial ovarian cancer: a phase 2, open-label, multicenter, randomized trial
por: Rob, Lukas, et al.
Publicado: (2022)

Immunological Network in Head and Neck Squamous Cell Carcinoma—A Prognostic Tool Beyond HPV Status
por: Fialová, Anna, et al.
Publicado: (2020)

Dendritic cells pulsed with tumor cells killed by high hydrostatic pressure induce strong immune responses and display therapeutic effects both in murine TC-1 and TRAMP-C2 tumors when combined with docetaxel chemotherapy
por: MIKYŠKOVÁ, ROMANA, et al.
Publicado: (2015)

The Role of TRIP6, ABCC3 and CPS1 Expression in Resistance of Ovarian Cancer to Taxanes
por: Seborova, Karolina, et al.
Publicado: (2021)

Targeting tumor-associated macrophages for successful immunotherapy of ovarian carcinoma
por: Truxova, Iva, et al.
Publicado: (2023)

Autologous dendritic cell immunotherapy (DCVAC/PCa) added to docetaxel chemotherapy in a Phase III trial (viable) in men with advanced (mCRPC) prostate cancer
por: Beer, Tomasz M, et al.
Publicado: (2015)

Tumor-infiltrating B cells affect the progression of oropharyngeal squamous cell carcinoma via cell-to-cell interactions with CD8(+) T cells
por: Hladíková, Kamila, et al.
Publicado: (2019)

Immunological configuration of ovarian carcinoma: features and impact on disease outcome
por: Fucikova, Jitka, et al.
Publicado: (2021)

Clinical Outcome of Coronavirus Disease 2019 in Patients with Primary Antibody Deficiencies
por: Milota, Tomas, et al.
Publicado: (2023)

Establishment and Characterization of a Highly Metastatic Ovarian Cancer Cell Line
por: Ruibin, Jiang, et al.
Publicado: (2018)

LL-37 as a Powerful Molecular Tool for Boosting the Performance of Ex Vivo-Produced Human Dendritic Cells for Cancer Immunotherapy
por: Stakheev, Dmitry, et al.
Publicado: (2022)

Hydrophilic Copolymers with Hydroxamic Acid Groups as a Protective Biocompatible Coating of Maghemite Nanoparticles: Synthesis, Physico-Chemical Characterization and MRI Biodistribution Study
por: Charvátová, Hana, et al.
Publicado: (2023)

Acute Conditioning of Antigen-Expanded CD8(+) T Cells via the GSK3β-mTORC Axis Differentially Dictates Their Immediate and Distal Responses after Antigen Rechallenge
por: Taborska, Pavla, et al.
Publicado: (2020)

The WNT/β-catenin signaling inhibitor XAV939 enhances the elimination of LNCaP and PC-3 prostate cancer cells by prostate cancer patient lymphocytes in vitro
por: Stakheev, Dmitry, et al.
Publicado: (2019)

Thapsigargin-Stimulated LAD2 Human Mast Cell Line Is a Potent Cellular Adjuvant for the Maturation of Monocyte-Derived Dendritic Cells for Adoptive Cellular Immunotherapy
por: Taborska, Pavla, et al.
Publicado: (2021)

Generation of dendritic cell-based vaccine using high hydrostatic pressure for non-small cell lung cancer immunotherapy
por: Hradilova, Nada, et al.
Publicado: (2017)

CD4(+) T Cells of Prostate Cancer Patients Have Decreased Immune Responses to Antigens Derived From SARS-CoV-2 Spike Glycoprotein
por: Taborska, Pavla, et al.
Publicado: (2021)

An experimental model for ovarian cancer: propagation of ovarian cancer initiating cells and generation of ovarian cancer organoids
por: Chen, Yu-An, et al.
Publicado: (2022)

A NOTCH1 Mutation Found in a Newly Established Ovarian Cancer Cell Line (FDOVL) Promotes Lymph Node Metastasis in Ovarian Cancer
por: Jiang, Wei, et al.
Publicado: (2023)

Establishment of a SVM classifier to predict recurrence of ovarian cancer
por: Zhou, Jinting, et al.
Publicado: (2018)

Protocol for establishing organoids from human ovarian cancer biopsies
por: Maenhoudt, Nina, et al.
Publicado: (2021)

Establishment of a piglet model for peritoneal metastasis of ovarian cancer
por: Lee, Eun Ji, et al.
Publicado: (2022)

Establishment and validation of an immune infiltration predictive model for ovarian cancer
por: Song, Zhenxia, et al.
Publicado: (2023)

Biological characteristics of side population cells in a self-established human ovarian cancer cell line
por: WEI, ZHENTONG, et al.
Publicado: (2016)

One-Step Accelerated Synthesis of Conducting Polymer/Silver Composites and Their Catalytic Reduction of Cr(VI) Ions and p-Nitrophenol
por: Minisy, Islam M., et al.
Publicado: (2023)

Cell therapies in ovarian cancer
por: Sarivalasis, Apostolos, et al.
Publicado: (2021)

ARHGAP10, downregulated in ovarian cancer, suppresses tumorigenicity of ovarian cancer cells
por: Luo, N, et al.
Publicado: (2016)

Switch of the ovarian cancer cell to a calcifying phenotype in the calcification of ovarian cancer
por: Wen, Jirui, et al.
Publicado: (2018)

Establishment, Characterization and Downstream Application of Primary Ovarian Cancer Cells Derived from Solid Tumors
por: Sueblinvong, Thanasak, et al.
Publicado: (2012)

Establishment and Characterization of the Novel High-Grade Serous Ovarian Cancer Cell Line OVPA8
por: Tudrej, Patrycja, et al.
Publicado: (2018)

Establishment of Epithelial Cell Culture from Ovarian Cancer Tissues: A Method Comparison Study
por: Anggraeni, Tricia Dewi, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_kpdk5d07jpvr5krg6s7m70tlqc